Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(15 sites)
United States
City of Hope Comprehensive Cancer Cente, Duarte, California
University of California Irvine, Irvine, California
Yale Cancer Center, New Haven, Connecticut
Dana-Farber Cancer Institute, Boston, Massachusetts
Rochester Skin Lymphoma Medical Group. PLLC, Rochester, New York
Virginia Commonwealth University Massey Comprehensive Cancer Cente, Richmond, Virginia
Australia
Westmead Hospital, Westmead, New South Wales
Epworth Healthcare, Melbourne, Victoria
Linear Clinical Research, Nedlands, Western Australia
France
CHU de Bordeaux - Hopital Saint André, Bordeaux, Bordeaux
Hopital Lyon Sud, Lyon, Pierre-Benite
Hopital Saint Louis, Paris, Île-de-France Region
Italy
IRCCS Azienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi, Bologna, Bologna
Universita degli Studi Di Brescia-Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia, Brescia
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele), Milan, Milano